Patent ID: 7056731

Claim:
An isolated nucleic acid molecule consisting essentially of a variant SULT2A1 nucleic acid sequence, wherein said variant SULT2A1 nucleic acid sequence is selected from the group consisting of: a) at least 10 contiguous nucleotides of SEQ ID NO:18, wherein said sequence includes nucleotide 1718 of SEQ ID NO:18, with the proviso that the nucleotide at position 1718 is adenine; b) at least 10 contiguous nucleotides of SEQ ID NO:2, wherein said sequence includes nucleotide 207 of SEQ ID NO:2, with the proviso that the nucleotide at position 207 is cytosine; c) at least 10 contiguous nucleotides of SEQ ID NO:2, wherein said sequence includes nucleotide 699 of SEQ ID NO:2, with the proviso that the nucleotide at position 699 is guanine; d) at least 10 contiguous nucleotides of SEQ ID NO:2, wherein said sequence includes nucleotide 801 of SEQ ID NO:2, with the proviso that the nucleotide at position 801 is adenine; and e) the complement of (a), (b), (c), or (d).